Core outcome sets in dermatology

report from the second meeting of the International Cochrane Skin Group Core Outcome Set Initiative

International Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN) group

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Results of clinical trials are the most important information source for generating external clinical evidence. The use of different outcomes across trials, which investigate similar interventions for similar patient groups, significantly limits the interpretation, comparability and clinical application of trial results. Core outcome sets (COSs) aim to overcome this limitation. A COS is an agreed standardized collection of outcomes that should be measured and reported in all clinical trials for a specific clinical condition. The Core Outcome Set Initiative within the Cochrane Skin Group (CSG-COUSIN) supports the development of core outcomes in dermatology. In the second CSG-COUSIN meeting held in 2017, 11 COS development groups working on skin diseases presented their current work. The presentations and discussions identified the following overarching methodological challenges for COS development in dermatology: it is not always easy to define the disease focus of a COS; the optimal method for outcome domain identification and level of detail needed to specify such domains is challenging to many; decision rules within Delphi surveys need to be improved; appropriate ways of patient involvement are not always clear. In addition, there appear to be outcome domains that may be relevant as potential core outcome domains for the majority of skin diseases. The close collaboration between methodologists in the Core Outcome Set Initiative and the international Cochrane Skin Group has major advantages for trialists, systematic reviewers and COS developers.

Original languageEnglish (US)
Pages (from-to)e279-e285
JournalBritish Journal of Dermatology
Volume178
Issue number4
DOIs
StatePublished - Apr 1 2018

Fingerprint

Dermatology
Clinical Trials
Skin Diseases
Skin
Patient Participation

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

International Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN) group. / Core outcome sets in dermatology : report from the second meeting of the International Cochrane Skin Group Core Outcome Set Initiative. In: British Journal of Dermatology. 2018 ; Vol. 178, No. 4. pp. e279-e285.
@article{57c45f2c2fad40c68ea31b6ec616215f,
title = "Core outcome sets in dermatology: report from the second meeting of the International Cochrane Skin Group Core Outcome Set Initiative",
abstract = "Results of clinical trials are the most important information source for generating external clinical evidence. The use of different outcomes across trials, which investigate similar interventions for similar patient groups, significantly limits the interpretation, comparability and clinical application of trial results. Core outcome sets (COSs) aim to overcome this limitation. A COS is an agreed standardized collection of outcomes that should be measured and reported in all clinical trials for a specific clinical condition. The Core Outcome Set Initiative within the Cochrane Skin Group (CSG-COUSIN) supports the development of core outcomes in dermatology. In the second CSG-COUSIN meeting held in 2017, 11 COS development groups working on skin diseases presented their current work. The presentations and discussions identified the following overarching methodological challenges for COS development in dermatology: it is not always easy to define the disease focus of a COS; the optimal method for outcome domain identification and level of detail needed to specify such domains is challenging to many; decision rules within Delphi surveys need to be improved; appropriate ways of patient involvement are not always clear. In addition, there appear to be outcome domains that may be relevant as potential core outcome domains for the majority of skin diseases. The close collaboration between methodologists in the Core Outcome Set Initiative and the international Cochrane Skin Group has major advantages for trialists, systematic reviewers and COS developers.",
author = "{International Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN) group} and J. Kottner and L. Jacobi and E. Hahnel and M. Alam and K. Balzer and D. Beeckman and C. Busard and J. Chalmers and S. Deckert and V. Eleftheriadou and K. Furlan and Horbach, {S. E.R.} and J. Kirkham and A. Nast and P. Spuls and D. Thiboutot and Diane Thiboutot and K. Weller and Williams, {H. C.} and J. Schmitt",
year = "2018",
month = "4",
day = "1",
doi = "10.1111/bjd.16324",
language = "English (US)",
volume = "178",
pages = "e279--e285",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Wiley-Blackwell",
number = "4",

}

Core outcome sets in dermatology : report from the second meeting of the International Cochrane Skin Group Core Outcome Set Initiative. / International Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN) group.

In: British Journal of Dermatology, Vol. 178, No. 4, 01.04.2018, p. e279-e285.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Core outcome sets in dermatology

T2 - report from the second meeting of the International Cochrane Skin Group Core Outcome Set Initiative

AU - International Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN) group

AU - Kottner, J.

AU - Jacobi, L.

AU - Hahnel, E.

AU - Alam, M.

AU - Balzer, K.

AU - Beeckman, D.

AU - Busard, C.

AU - Chalmers, J.

AU - Deckert, S.

AU - Eleftheriadou, V.

AU - Furlan, K.

AU - Horbach, S. E.R.

AU - Kirkham, J.

AU - Nast, A.

AU - Spuls, P.

AU - Thiboutot, D.

AU - Thiboutot, Diane

AU - Weller, K.

AU - Williams, H. C.

AU - Schmitt, J.

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Results of clinical trials are the most important information source for generating external clinical evidence. The use of different outcomes across trials, which investigate similar interventions for similar patient groups, significantly limits the interpretation, comparability and clinical application of trial results. Core outcome sets (COSs) aim to overcome this limitation. A COS is an agreed standardized collection of outcomes that should be measured and reported in all clinical trials for a specific clinical condition. The Core Outcome Set Initiative within the Cochrane Skin Group (CSG-COUSIN) supports the development of core outcomes in dermatology. In the second CSG-COUSIN meeting held in 2017, 11 COS development groups working on skin diseases presented their current work. The presentations and discussions identified the following overarching methodological challenges for COS development in dermatology: it is not always easy to define the disease focus of a COS; the optimal method for outcome domain identification and level of detail needed to specify such domains is challenging to many; decision rules within Delphi surveys need to be improved; appropriate ways of patient involvement are not always clear. In addition, there appear to be outcome domains that may be relevant as potential core outcome domains for the majority of skin diseases. The close collaboration between methodologists in the Core Outcome Set Initiative and the international Cochrane Skin Group has major advantages for trialists, systematic reviewers and COS developers.

AB - Results of clinical trials are the most important information source for generating external clinical evidence. The use of different outcomes across trials, which investigate similar interventions for similar patient groups, significantly limits the interpretation, comparability and clinical application of trial results. Core outcome sets (COSs) aim to overcome this limitation. A COS is an agreed standardized collection of outcomes that should be measured and reported in all clinical trials for a specific clinical condition. The Core Outcome Set Initiative within the Cochrane Skin Group (CSG-COUSIN) supports the development of core outcomes in dermatology. In the second CSG-COUSIN meeting held in 2017, 11 COS development groups working on skin diseases presented their current work. The presentations and discussions identified the following overarching methodological challenges for COS development in dermatology: it is not always easy to define the disease focus of a COS; the optimal method for outcome domain identification and level of detail needed to specify such domains is challenging to many; decision rules within Delphi surveys need to be improved; appropriate ways of patient involvement are not always clear. In addition, there appear to be outcome domains that may be relevant as potential core outcome domains for the majority of skin diseases. The close collaboration between methodologists in the Core Outcome Set Initiative and the international Cochrane Skin Group has major advantages for trialists, systematic reviewers and COS developers.

UR - http://www.scopus.com/inward/record.url?scp=85042006598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042006598&partnerID=8YFLogxK

U2 - 10.1111/bjd.16324

DO - 10.1111/bjd.16324

M3 - Article

VL - 178

SP - e279-e285

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - 4

ER -